Impel Neuropharma raises $80M in Washington state’s first IPO of 2021

0
Impel CEO Adrian Adams. (Impel Photo)The news: Seattle-based biotech company Impel NeuroPharma raised $80 million in its initial public offering and will begin trading on the NASDAQ Friday. It is the first Washington state company to go public in 2021 via a traditional IPO. Company background: Founded in 2008, Impel is a late-stage pre-revenue pharma company that develops drugs for…
« Previous post: | Next post: »